Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial
dc.contributor.author | Keene, Keith L. | |
dc.contributor.author | Chen, Wei-Min | |
dc.contributor.author | Chen, Fang | |
dc.contributor.author | Williams, Stephen R. | |
dc.contributor.author | Elkhatib, Stacey D. | |
dc.contributor.author | Hsu, Fang-Chi | |
dc.contributor.author | Mychaleckyj, Josyf C. | |
dc.contributor.author | Doheny, Kimberly F. | |
dc.contributor.author | Pugh, Elizabeth W. | |
dc.contributor.author | Ling, Hua | |
dc.contributor.author | Laurie, Cathy C. | |
dc.contributor.author | Gogarten, Stephanie M. | |
dc.contributor.author | Madden, Ebony B. | |
dc.contributor.author | Worrall, Bradford B. | |
dc.contributor.author | Sale, Michele M. | |
dc.date.accessioned | 2016-06-03T16:16:18Z | |
dc.date.available | 2016-06-03T16:16:18Z | |
dc.date.issued | 2014-08 | |
dc.description.abstract | Background: B vitamins play an important role in homocysteine metabolism, with vitamin deficiencies resulting in increased levels of homocysteine and increased risk for stroke. We performed a genome-wide association study (GWAS) in 2,100 stroke patients from the Vitamin Intervention for Stroke Prevention (VISP) trial, a clinical trial designed to determine whether the daily intake of high-dose folic acid, vitamins B6, and B12 reduce recurrent cerebral infarction. Methods: Extensive quality control (QC) measures resulted in a total of 737,081 SNPs for analysis. Genome-wide association analyses for baseline quantitative measures of folate, Vitamins B12, and B6 were completed using linear regression approaches, implemented in PLINK. Results: Six associations met or exceeded genome-wide significance (P ≤ 5 × 10−08). For baseline Vitamin B12, the strongest association was observed with a non-synonymous SNP (nsSNP) located in the CUBN gene (P = 1.76 × 10−13). Two additional CUBN intronic SNPs demonstrated strong associations with B12 (P = 2.92 × 10−10 and 4.11 × 10−10), while a second nsSNP, located in the TCN1 gene, also reached genome-wide significance (P = 5.14 × 10−11). For baseline measures of Vitamin B6, we identified genome-wide significant associations for SNPs at the ALPL locus (rs1697421; P = 7.06 × 10−10 and rs1780316; P = 2.25 × 10−08). In addition to the six genome-wide significant associations, nine SNPs (two for Vitamin B6, six for Vitamin B12, and one for folate measures) provided suggestive evidence for association (P ≤ 10−07). Conclusion: Our GWAS study has identified six genome-wide significant associations, nine suggestive associations, and successfully replicated 5 of 16 SNPs previously reported to be associated with measures of B vitamins. The six genome-wide significant associations are located in gene regions that have shown previous associations with measures of B vitamins; however, four of the nine suggestive associations represent novel finding and warrant further investigation in additional populations. | en_US |
dc.identifier.citation | Frontiers in Public Health; 2: p. 1-8 | en_US |
dc.identifier.doi | 10.3389/fpubh.2014.00112 | |
dc.identifier.issn | 2296-2565 | |
dc.identifier.pmid | pmc4123605 | en_US |
dc.identifier.uri | http://hdl.handle.net/10342/5452 | |
dc.relation.uri | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123605/ | en_US |
dc.subject | VISP | en_US |
dc.subject | association | en_US |
dc.subject | GWAS | en_US |
dc.subject | one-carbon metabolism | en_US |
dc.subject | B12 | en_US |
dc.subject | B6 | en_US |
dc.subject | folate | en_US |
dc.title | Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial | en_US |
dc.type | Article | en_US |
ecu.journal.name | Frontiers in Public Health | en_US |
ecu.journal.pages | 1-8 | en_US |
ecu.journal.volume | 2 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- fpubh-02-00112.PMC4123605.pdf
- Size:
- 874.21 KB
- Format:
- Adobe Portable Document Format